FEATURED SLIDESHOW
Who Is The Worst CEO?Mad Money needed new inductees for its
Wall of Shame, so we asked viewers for
nominations.
RECENT POSTS
- Time to Buy Treasurys?
- Lightning Round: Las Vegas Sands, ADC Telecom, Satyam Computer and More
- Lightning Round OT: Knight Capital, Ebix and More
- Is Lear, Back From Bankruptcy, a Buy?
- Sanofi-Aventis Falling Off a Patent Cliff?
- Cramer: Your Thanksgiving Week Game Plan
- Cramer: Next Week Should Define Rest of ‘09
- Mad Money: Mad Mail: Buy RIM or Apple?
- Lightning Round: Cisco Systems, Citigroup, Baidu.com and More
- Lightning Round OT: Martek Biosciences, Valmont Industries and More
Road Rules
Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Text Size 
Oct.31
8:02 PM ET
Wednesday, 31 Oct 2007
On the Line: Nastech Pharma CEO Dr. Stephen Quay
Posted By:Tom Brennan
Topics:Pharmaceuticals | Stock Picks | Stock Market
Sectors:Health Care
Companies:Nastech Pharmaceutical Co
Wall Street wasn't happy about Nastech Pharma's latest quarter, so Cramer brought Chairman, CEO and President Dr. Steven Quay on Mad Money to find out what was going on.
Watch the video to get Quay's outlook on Nastech's [NSTK
Loading...
()
] "multiple shots on goal" approach to business, the reason for Procter & Gamble's [PG
Loading...
()
] hold on a $5 million payment, and why the company's nasal delivery system will succeed where others haven't.
Click for the rest of Wednesday's show
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?
MORE FROM CNBC
Data is a real-time snapshot *Data is delayed at least 15 minutes